they found significant decreases in the levels of KRAS, RHOA, RAC1, and CDC42 ranging within 20–66% after NSL-YHJ-2-27 (5 μM) treatment in all four cell lines tested, A549, NCI-H1299 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback